PORT-6
Phase 1- Indications
- Cancer
Company intelligence / Profile preview
Portage Clinical Trials
Delaware or Massachusetts, United Statesportagebiotech.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Portage Biotech is a clinical-stage immuno-oncology company advancing first-in-class therapies targeting immune resistance pathways in solid tumors. Its leading candidates include selective adenosine A2A/A2B receptor antagonists and invariant natural killer T-cell engagers. Recent results show promising preclinical efficacy in mesothelioma with PORT‑7 and ongoing Phase Ia/Ib trials of PORT‑6/PORT‑7 in multiple solid tumor types. The company’s diversified pipeline spans five drug platforms with ten products at various stages from preclinical to early clinical development.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeVirus-like drug conjugate (VDC)Shared antigen vaccineBiologicCell therapy (iNKT cell agonists/engagers)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
National Cancer Institute (NCI) academic collaborationMajor academic institutionsearly engagement with Big Pharma partners for asset feedback/licensing potential.
Beyond the preview
Go deeper on Portage Clinical Trials.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Portage Clinical Trials.